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A novel cDNA clone encoding a putative G protein-coupled receptor (named GPCR21) was isolated from a mouse brain cDNA library along with 
its homologue, GPCROl (the mouse counterpart of previously reported rat receptor R334 [(1991) FEBS Lett. 292, 243-2481) by the polymerase 
chain reaction using degenerate oligonucleotide primers. Northern blotting and reverse transcription-polymerase chain reaction analyses howed 
predominant expression of these two receptors in the central nervous system. In situ hybridization analysis revealed their prominent expression 
in the limbic system and further demonstrated the differential distribution of their mRNAs in mouse brain. Although the ligands for these receptors 
are yet to be identified, the significant sequence homology between these receptors uggests that they constitute a new receptor subfamily and they 
possibly represent different receptor subtypes for an unknown neurotransmitter. 
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1. INTRODUCTION 
The wide spectrum of intercellular signals mediated 
by hormones, neurotransmitters and neuropeptides are 
transduced into cells via their specific receptors that 
interact with the guanine nucleotide-binding regulatory 
protein (G protein) signaling system [1,2]. Recent mo- 
lecular cloning studies have led to the identification of 
a growing number of receptors of this class, G protein- 
coupled receptors [3,4,5]. Sequence comparison of these 
receptors suggests that all members of the receptor fam- 
ily have a specific tertiary structure in common, con- 
taining an extracellular amino-terminus and seven hy- 
drophobic membrane spanning a-helices [3]. Among 
these receptors, there is a degree of sequence conserva- 
tion within the putative transmembrane regions. The 
identification and characterization of new members of 
the receptor superfamily, taking advantage of their se- 
quence similarities, would facilitate the understanding 
of functional domains and essential residues of the re- 
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The nucleotide sequence data of GPCROl and GPCR21 have been 
submitted to the DDBJlEMBUGenBank Data Libraries under acces- 
sion numbers D21061 and D21062, respectively. 
ceptors and provide models for the G protein signaling 
systems. 
2. MATERIALS AND METHODS 
2.1. RNA preparation and polymerase chain reaction (PCR) 
Total RNA was prepared from mouse whole brain using the acid 
guanidinium thiocyanate-phenol-chloroform method [6] and 
poly(A)+ RNA was selected using Oligotex-dT30 (Takara). First 
strand cDNA was synthesized with random hexamer and MMLV 
reverse transcriptase and then was subjected to PCR amplification 
using a set of degenerate oligonucleotide primers corresponding to 
conserved sequences of the third and sixth transmembrane domains 
among the known G protein-coupled receptors (TMSF: 
Y-ATCCGAATTCTGTGIG(C/T)(GIC)ATC(A/G)(G/C)CITIGA- 
(C/T)(A/C)G(G/C)T; TM6R:5’-AGATGTCGACGAAGAAGGGC- 
(A/G)ICCA(G/A)CAG(A/C)II(A/G)(G/C/T)(A/G)AA, modified 
from the primers reported by Libert et al. [l/1). The conditions of the 
PCR were as follows: 94’C, 1 min (denaturation); 55°C 1 min (an- 
nealing); 72’C, 2 min (extension); 35 cycles. The amplified cDNA 
fragments were cloned into Ml3 phage vectors for sequencing. Out of 
62 clones analyzed, two clones (MB10 and MBWS) were found to have 
unreported sequences with conserved receptor motifs (the sequence 
data of the full-length cDNA clone for the MB10 was submitted to 
the DDBJlEMBUGenBank Data Libraries under the accession um- 
ber D17292). 
2.2. cDNA library screening and DNA sequencing 
In order to obtain the complete cDNA fragment for the clone 
MBWS, about 1 x lo6 clones from a phage 1gtlO mouse brain cDNA 
library were screened with the MBWS cDNA fragment labeled with 
[a-32P]dCTP by the random priming method [8]. Hybridization was 
performed at 53°C in 6 x SSC (1 x SSC is 0.15 M NaCl plus 0.015 M 
sodium citrate), 1 x Denhardt’s solution, 0.5% SDS and 150 ,@ml 
salmon sperm DNA. The filters were washed in 0.2 x SSC and 0.1% 
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SDS at 53°C and were autoradiographed. As a result, 11 positive 
clones were isolated. Restriction fragment length polymorphism anal- 
ysis revealed the clone termed GPCROl had a cDNA species different 
from the other 10 clones. The clone GPCR21 with the longest insert 
among the 10 clones and GPCROl were subcloned into Ml3 phage 
vectors or Bluescript II plasmid vectors. Both strands of the cDNA 
clones were sequenced using Taq Dye Primer Cycle Sequencing Kit 
and 373A DNA autosequencer (Applied Biosystems). 
2.3. Northern blot analysis and reverse transcription-PCR (RT-PCR) 
analysis 
Total RNA and poly(A)’ RNA were prepared from various mouse 
tissues in the method described in section 2.1 above. For Northern blot 
analysis, the RNA samples were electrophoresed on formaldehyde/ 
0.9% agarose gels and transferred to Hybond-N nylon membranes 
(Amersham). The membranes were hybridized with “P-labeled 
GPCROl or GPCR21 cDNA at 42°C in 50% formamide, 6 x SSC, 
4 x Denhardt’s olution, 1% SDS and 150 ,ug/ml salmon sperm DNA. 
The filters were washed at high stringency in a final wash of 0.2 x SSC, 
0.1% SDS at 65°C. Two sets of oligonucleotide primers were synthe- 
sized for the analytical PCR amplification of reverse transcribed 
mRNAs for GPCROl and GPCR21; GPCROl-F: 5’-GAA- 
CAACGCTGCCATCCTCT, and GPCROl-R: 5’-CTTGTGA- 
GATCCAGTGCAAA; GPCR21-F: S-CACTCTCCAAGAAC- 
CATCTG (corresponding to 1064-1083; Fig. 1) and GPCR21-R: 5’- 
TCTGGAACATTCTAGAGCCA (corresponding to 1675-1694; Fig. 
1). Total RNA samples were treated with RNase-free DNase I to 
avoid contamination of genomic DNA. First strand cDNA reverse 
transcribed from 100 ng of total RNA was amplified in a 5-~1 reaction 
volume in the presence of [a-‘*P]dCTP. The PCR run consists of 25 
cycles of 45 s at 94”C, 60 s at 6O’C and 60 s at 72°C. Each amplified 
sample was electrophoresed on 6% polyacrylamide gels. The gels were 
dried and exposed to Kodak X-Omat AR film. 
2.4. In situ hybridization analysis 
In situ hybridization was performed using ‘?S-labeled cRNA probes 
as reported by Mizuno et al. [9]. 10 pm cryostat sections of adult 
mouse brains were hybridized with GPCROl and GPCR21 riboprobes 
(3 x lo6 cpm/ml) at 57’C in 50% formamide and 0.6 M NaCl, 1 x Den- 
hardt’s solution, 10% dextran sulfate and 100 ,&g/ml yeast tRNA and 
lOOpg/ml salmon sperm DNA. The sections were washed, treated with 
RNase A and then washed stringently in 2 x SSC at 55°C for 1 h, 
followed by 0.1 x SSC at 55°C for 3 h. The sections were exposed to 
X-ray film and then were dipped in Kodak NTB3 emulsion. Hybridi- 
zation specificity was controlled using sense RNA probes. 
2.5. Eukaryotic expression of GPCZUI 
The entire coding region of GPCR21 cDNA (corresponding to 
493-1684; Fig. 1) was cloned into pRc/RSV vector (Invitrogen) and 
transfected using LipofectAMINE Reagent (BRL) into CHO-Kl 
cells. The transfectants were selected by G418 and were examined for 
the expression of GPCR21 by Northern blot analysis of cellular RNA. 
Cells were maintained in F-12 media with 10% fetal calf serum, ka- 
namycin (50 &ml) and G418 (400 fig/ml) and incubated at 37°C in 
5% CO2 until use. CHO-Kl cells were provided by Japanese Cancer 
Resources Bank-Cell. 
i:et Mer Trp G;_J Aid G;ji Ser Ser Met Ala Trp Phe Ser ~1s 
0 
Gly Ser Gly Ser Val Asn Val Ser Ser Val Asp Pro Val Glu Glu Pro Thr 31 
AX iTr, ?r,G GGX GCA GGA AGC XT A'X GCC 'EG T?C TCA G('T GGC TCX GGC MT GTC AAC GTG AGC AC< GE GAC CCA GTA GAG GAA CCC ACA 
I 
Glj, Pro Xa Thr iexu Leu Pro Ser Pro Ara Ala Tn, As a V 1 V -al Leu 0% Ile Ser Glv Thr Leu V&l Ser 0,s Glu Asn Ala Leu Val '?a1 62 
GGC CC.4 GCT ACA CTG C'E CCC TCT CCC AGG GCC TGG GA'7 GTG GTG CTG TGC AW WA GGC ACC CT".2 GTG 'KC %C GAG AAC GCG C'IG GTG GE 
Ala Iie Ile Yal Giy Thr Pro Ala Phe Arg Ala Pro Met Phe Leu Leu Val Glv Ser Leu Ala Val Ala ASD Leu Leu Aia Glv Leu Glv Ley 93 
GCC AT AT? GTG GGC ACT CCT GCC TTC CGC GCC CCC ATG T'X C-E CTG GTG GGT AGC 'I% GCC GTA GCA GAC CTG CTG GCA GGC CE GGC CT'2 
III 
:5 i :e'z ii::5 ;he ala ala Asp Phe Cfs Ile Giy Ser Pro Glu Met Ser Leu Met Leu l;ai Glv Val Leu Ala Met Ala Phe Thr Ala Ser Ile 12.i 
GTC CTG CAC T?'I GCG GCT GAC TX' TGC A'FI GGC 'KA CCA GAG A% AGC 'FE AE CTG GTC GGC G?T. CTA GCA AT'2 GCC T'K ACT GCC AGC AX 
Glv Ser ieu Leil ALa Ile Thr Vak Asp Arg 'lyr Leu Ser Leu Tyr Asn Ala Leu Thr 'Wr Wr Ser Glu Thr Thr Val Thr Arg Thr 'Wr Val 155 
GGC AGC CTG CTG GCC ATT ACC GT'I GAC CGC TAC CTT KC Cn: TAC AAT GCT CTC ACT TAC TAC 'KA GAG ACA ACG GTA ACT CGG ACT TAT GTG 
IV 
b!et Leu Ala Leu Val Tm Val Glv Ala Leu Glv Leu Glv Leu Val Pro Val Leu Ala Tm Asn CYS Arg ASP Gly Leu Thr Thr Q'S Gly Val 186 
A'E CTG GCC TM; GTG 'KG G'IG GGT GCC CTG GGC CTG GGG CTG GTT CCC GTG CX GCC TGG AAC 'EC CGG GAT GGC Cn; ACC ACG 'ET GGT G'E 
V 
:'al w;?ir Pro Leu Ser L~s Asn HIS Leu Val Val Leu Ala Ile Ala Phe Phe Met Val Phe Glv Ile Met Leu Gin ieu 'Wr Ala Gln Ile CVZ 317 
GTC TAT CC,? CTC TCC AAG AAC CAT CTG GTG GTT CTG GCC ATC GCC TX TIC A'X GTG TTT GGC ATC ATG TX CAG CX TAT GCC CAG ATC TGC 
‘rg Ile Val Cys Arg HIS Ala Gln Gln Ile Ala Leu Gln Arg HIS Leu Leu Pro Ala Ser HIS Tyr Val Ala Thr Arg LyS Gly Jle Ala Thr 248 
CGC AK G'K XC CGC CAT GCC CAG CAG ATC 3CC CX CAA CGA CAC Cn; C'E CCT GCC 'XT CAC TAC G?I: GCC ACC CGC AAG GGC A'IK GCC ACA 
Leil Ala .ial Val Leu Giv Ala Phe Ala Ala Cv ,v*T, Leu Pro Phe Thr Val 'Wr Cvs Leu Leu Giv ASD Ala Asp Ser PTO Arg Leu YIW Thr 279 
TX GCT GTG GTG CTT GGC GCC TTI GCT GCC ET TGG TTG CCC TTC ACT G'K TAC XX CTC CTG GGA GAT GCC GAC TCT CCC CGT C?c TAC ACC 
T<\ir ieu mr Leu Leu Pro Al%hr Tv r Asn Ser Met Ile Asn Pro Val Ile Tvr Ala Phg Arg Rsn Gln Asp Val Gin LYS Val Leu Trp Aia ill: 
TAT CT-7 i. CC CTG CTC CCA GCC ACC TAC AX XC ATG ATC AAC CC T GTC A'X TAC GCC TTT CGC AK CAA GAT GE CAG AAG GTG C'K TGG GCC 
IiE. Cy5 Q’S CyS CyS Ser Thr Ser Lys Ile Pro Fhe Arg Ser Arg Ser Pro Ser Asp i'al *** 33'? 
ATC 'EC T!X TGC ET TCC ACT XC AAG ATT CCA 7°K CGG TCC CGG TCC CCT AGT GAT GTC TAG TTTCArrCTGGTG~CC~~GCT~ACTACTATAG~ 
Fig. 1. Nucleotide and deduced amino amino acid sequence of putative GPCR21 receptor. Stop codon is indicated by ***. A potential N-linked 
glycosylation site in the NH,-terminal region and phosphorylation sites in the COOH-terminal region are denoted by l and v, respectively. The 
putative transmembrane domains I-VII are underlined and are assigned on the basis of a Kyte and Doolittle hydropathicity plot [l 11. 
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Fig. 2. RNA blot analysis of GPCR21 (left) and GPCROl (right). Each 
lane contains 1Opg sample ofpoly(A)’ RNA prepared from forebrain, 
hindbrain, testis and liver of adult male mouse. The film was exposed 
at -7O’C for a week. The transcript of GPCRZI was detected as bands 
at 2.6 kb with approximately the same intensity both in forebrain and 
hindbrain. Messenger RNA for GPCROl was observed predomi- 
nantly in forebrain and to a lesser extent in hindbrain. 
3. RESULTS AND DISCUSSION 
In order to isolate new members of the G protein- 
coupled receptor family expressed in mouse central 
nervous system, RT-PCR was performed with poly(A)’ 
RNA prepared from mouse whole brain. The amplified 
cDNA fragments were cloned into Ml3 vectors and 
were sequenced. The clone, termed MBWS, was found 
to have a 43-bp insert of unreported sequence with con- 
served receptor motifs. Screening of a mouse brain 
cDNA library with this partial cDNA fragment resulted 
in isolation of the full-length clone (GPCR21) for 
MBWS as well as its homologous clone (GPCROl). 
Both clones were subjected to sequencing analysis on 
both strands. 
The nucleotide sequence of clone GPCR21 specifies 
a 990-bp open reading frame coding for a 330~amino 
acid protein with a molecular weight of 35.5 kDa (Fig. 
1). The presence of an in-frame stop codon in the 5’- 
upstream and the close match of the initiator ATG to 
the Kozak consensus sequence [lo] indicates that the 
clone contains the entire coding region. According to 
hydropathicity analysis [l l] (data not shown), the pre- 
dicted polypeptide contains seven highly hydrophobic 
regions of 20-30 amino acids separated by stretches of 
more hydrophilic sequences, typical for the G protein- 
coupled receptor superfamily [3,12]. The receptor con- 
tains a potential N-linked glycosylation site at AsnzO [131 
in the amino-terminal region. There are conserved pro- 
line residues in the fourth, sixth and seventh transmem- 
brane domains (Pro”l, Pro”’ and P~o*~~). These resi- 
dues producing a bend in the a-helical structure may be 
important in the binding pocket formation [14]. The 
presence of the consensus phosphorylation sites in the 
carboxyl-terminal region at Ser326 and Ser3** (calmod- 
ulin-dependent protein kinase sites) [15] suggests that 
the function of this receptor is modulated by phospho- 
rylation. 
Sequencing analysis of GPCROl revealed that the 
longest open reading frame in the clone encodes a 334 
amino acid residue protein. Homology searching of 
GPCROl sequence on the GenBank database revealed 
that GPCROl was the mouse counterpart of a previ- 
ously reported rat orphan receptor R334 (91.4% and 
89.7% identity in nucleotide sequence and amino acid 
sequence, respectively) [16]. GPCR21 and GPCROl 
showed high sequence homology, 57.0% identity in 
amino acid sequence. The sequence identity between 
these receptors rises to 64.4% for the transmembrane 
residues, suggesting that the ligands for these receptors 
are likely to be identical or similar [17]. 
Northern blot analysis was performed to investigate 
the expression of GPCR21 in mouse tissues. As shown 
in Fig. 2, a mRNA species, approximately 2.6 kb in size, 
was detected in both forebrain and hindbrain. A faint 
band of the same size was also observed in testis. On the 
other hand, GPCROI was expressed predominantly in 
forebrain and, to a lesser extent, in hindbrain. We also 
performed RT-PCR analysis using total RNA prepared 
from various mouse tissues (Fig. 3). The DNA frag- 
ments of 631 bp amplified from GPCR21 transcript 
were detected in various regions of brain and in testis 
but in no other tissues or organs examined. The inten- 
sive bands for GPCROl (518 bp) were detected in fron- 
tal cortex, thalamus and hypothalamus. Although 
R334, the rat counterpart of GPCROl, was reported to 
be expressed in testis [16], our result showed that 
GPCROl was expressed in liver rather than testis in 
mouse. The more precise distribution of mRNAs for 
these receptors in mouse brain was studied by in situ 
hybridization analysis (Fig. 4). GPCR21 was found to 
be expressed prominently in medial habenular nucleus 
and weaker signals were detected in cerebral cortex, 
Fig. 3. RT-PCR analysis of GPCR21 and GPCROl. First strand cDNA reverse transcribed from total RNA prepared from various mouse tissues 
were amplified and then separated by electrophoresis on 6% polyacrylamide gels. The upper bands of 631 bp in size represent he expression of 
GPCR21, while the lower bands of 518 bp represent hat of GPCROl. 
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Fig. 4. Localizations of mRNAs for GPCR21 and GPCROl by in situ 
hybridization analysis. Horizontal (A,C,E) and coronal (B,D) sections 
of mouse brains were hybridized with the antisense cRNA probe for 
either GPCR21 (A,B,E) or GPCROl (C,D). The slices were exposed 
to X-ray film for 10 days at -7O’C. GPCR21 was highly expressed in 
medial habenular nucleus and only low levels of expression were 
detected in other regions of brain. The dark-field micrograph of emul- 
sion dipped section through epithalamus (E) showed the high density 
of GPCR21 mRNA in medial habenular nucleus. Strong signals for 
GPCROl were detected in hippocampus, amygdala, piriform cortex 
and olfactory bulb. Significantly high signals were also observed in 
thalamus, striatum, ventromedial hypothalamic nuclei and cerebral 
cortex. MHb, medial habenular nucleus; V, third ventricle. 
hippocampus, olfactory bulb and striatum. GPCROl, 
on the other hand, was expressed highly in hippocam- 
pus (granular cells of the dentate gyrus and CA2-3) 
amygdaloid nuclei, piriform cortex and olfactory bulb 
(external granular lamina and mitral cellular lamina). 
Significant levels of signals were also observed in thala- 
mus, striatum, ventromedial hypothalamic nuclei and 
cerebral cortex. 
Searching protein database revealed the highest ho- 
mology of GPCR21 to the rat orphan receptor R334 
(52.1% identity). In addition, GPCR21 showed signifi- 
cant similarities to melanocortin receptors (MSH recep- 
tor, 29.1%; ACTH receptor, 25.5% [4]), cannabinoid 
receptor (27.8%, [18]), adenosine receptors (Al, 26.0% 
[19]; A2a, 25.0% [7]; and A3, 28.8% [5]) and H2 hista- 
mine receptor (28.8% [20]). Multiple alignment of 
GPCR21 and GPCROl with five other members of G 
protein-coupled receptors in shown in Fig. 5. 
In order to identify a ligand for GPCR21, CHO-Kl 
cells stably expressing GPCR21 were tested for the 
changes of both cyclic AMP (CAMP) contents and ino- 
sitol 1,4,5_triphosphate (IP,) contents in response to 
various commercially available ligands. However, none 
of the substances examined affected the CAMP level of 
the IP, level. 
We have obtained a novel cDNA clone encoding a 
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Fig. 5. Comparison of the amino acid sequences of the GPCR21, GPCROl and five other members of G protein-coupled receptors (MSHR, human 
MSH receptor [4]; ACTHR, human ACTH receptor [4]; CANNABR, rat cannabinoid receptor [18]; AlADENR, rat Al adenosine receptor [19]; 
and /?2ADRER, human /3* adrenergic receptor [21]). Predicted transmembrane domains are numbered and indicated by a solid black line above 
the sequences. Gaps, indicated by hyphens, are introduced to obtain maximal homology. Amino acids identical to GPCR21 or GPCROl are denoted 
in boldface. 
putative mouse G protein-coupled receptor (GPCR21) 
along with its homologue (GPCROl). Based on the ex- 
tremely high sequence similarity between them, we as- 
sume that their ligands are identical or closely related. 
Although the ligands for these receptors have not been 
identified, the predominant expression of their mRNAs 
in the limbic system of mouse brain suggest that they 
might be involved in a diverse set of behavioral func- 
tions, which include olfaction, ingestion, sexual behav- 
ior, endocrine function, autonomic function and brain 
stimulation. Since mRNA for GPCR21 was also de- 
tected in testis, it can be speculated that these receptors 
may play an important role in the neural regulation of 
sexual and/or eproductive functions. Thus, further 
characterization of these receptors, as well as the identi- 
fication of their ligands, may contribute to our under- 
standing of neuro-endocrine-behavioral modulation. 
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